Aberrant NMDA receptor DNA methylation detected by epigenome-wide analysis of hippocampus and prefrontal cortex in major depression
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Current perspectives on the molecular underpinnings of major depressive disorder (MDD) posit a mechanistic role of epigenetic DNA modifications in mediating the interaction between environmental risk factors and a genetic predisposition. However, conclusive evidence for differential methylation signatures in the brain's epigenome of MDD patients as compared to controls is still lacking. To address this issue, we conducted a pilot study including an epigenome-wide methylation analysis in six individuals diagnosed with recurrent MDD and six control subjects matched for age and gender, with a priori focus on the hippocampus and prefrontal cortex as pathophysiologically relevant candidate regions. Our analysis revealed differential methylation profiles of 11 genes in hippocampus and 20 genes in prefrontal cortex, five of which were selected for replication of the methylation status using pyrosequencing. Among these replicated targets, GRIN2A was found to be hypermethylated in both prefrontal cortex and hippocampus. This finding may be of particular functional relevance as GRIN2A encodes the glutamatergic N-methyl-D-aspartate receptor subunit epsilon-1 (NR2A) and is known to be involved in a plethora of synaptic plasticity-related regulatory processes probably disturbed in MDD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Twenty genes are found to be differentially methylated in PFC of MDD patients from a genome-wide methylation analysis, including hypermethylation of Grin2a 232.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [232]
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Epigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.008 · Cited by 773
Gene Body-Specific Methylation on the Active X Chromosome
Hellman, A., & Chess, A. (2007) · Science · doi:10.1126/science.1136352 · Cited by 729
The Genetics of Major Depression
Flint, J., & Kendler, K. S. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.027 · Cited by 724
Moghaddam, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13387.x · Cited by 567
Touleimat, N., & Tost, J. (2012) · Epigenomics · doi:10.2217/epi.12.21 · Cited by 507
Fitzgerald, L., Ortiz, J., Hamedani, A., & Nestler, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00274.1996 · Cited by 450
Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Lynx1, a Cholinergic Brake, Limits Plasticity in Adult Visual Cortex
Morishita, H., Miwa, J. M., Heintz, N., & Hensch, T. K. (2010) · Science · doi:10.1126/science.1195320 · Cited by 365
Exploring and explaining epigenetic effects
Henikoff, S., & Matzke, M. A. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01219-5 · Cited by 307
Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients
Rao, J. S., Keleshian, V. L., Klein, S., & Rapoport, S. I. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.55 · Cited by 304
Epigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277
Beneyto, M., & Meador-Woodruff, J. H. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301604 · Cited by 259
Boyce-Rustay, J. M., & Holmes, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301039 · Cited by 208
Bartanusz, V., Aubry, J.-M., Pagliusi, S., Jezova, D., Baffi, J., & Kiss, J. Z. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00084-v · Cited by 183
Choroid-Plexus-Derived Otx2 Homeoprotein Constrains Adult Cortical Plasticity
Spatazza, J., Lee, H. H. C., Di Nardo, A. A., Tibaldi, L., Joliot, A., Hensch, T. K., & Prochiantz, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.014 · Cited by 176
Tadić, A., Müller-Engling, L., Schlicht, K. F., Kotsiari, A., Dreimüller, N., Kleimann, A., Bleich, S., Lieb, K., & Frieling, H. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.58 · Cited by 175
Cherlyn, S. Y. T., Woon, P. S., Liu, J. J., Ong, W. Y., Tsai, G. C., & Sim, K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.002 · Cited by 165
Akashi, K., Kakizaki, T., Kamiya, H., Fukaya, M., Yamasaki, M., Abe, M., Natsume, R., Watanabe, M., & Sakimura, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5531-08.2009 · Cited by 163
Inhibition of Glycine Transporter-I as a Novel Mechanism for the Treatment of Depression
Huang, C., Wei, I., Huang, C.-L., Chen, K.-T., Tsai, M., Tsai, P., Tun, R., Huang, K.-H., Chang, Y., Lane, H., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.020 · Cited by 152
Kaut, O., Schmitt, I., & Wüllner, U. (2012) · Neurogenetics · doi:10.1007/s10048-011-0308-3 · Cited by 145
Self-citationElevated levels of NR2A and PSD-95 in the lateral amygdala in depression
Karolewicz, B., Szebeni, K., Gilmore, T., Maciag, D., Stockmeier, C. A., & Ordway, G. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008985 · Cited by 143
New paradigms for treatment‐resistant depression
Zarate, C., Duman, R. S., Liu, G., Sartori, S., Quiroz, J., & Murck, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12223 · Cited by 109
Murrough, J. W., Wan, L.-B., Iacoviello, B., Collins, K. A., Solon, C., Glicksberg, B., Perez, A. M., Mathew, S. J., Charney, D. S., Iosifescu, D. V., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3255-x · Cited by 108
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., & Riva, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037916 · Cited by 107
Elevated Levels of the NR2C Subunit of the NMDA Receptor in the Locus Coeruleus in Depression
Karolewicz, B., Stockmeier, C. A., & Ordway, G. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300781 · Cited by 81
Prömel, S., Waller‐Evans, H., Dixon, J., Zahn, D., Colledge, W. H., Doran, J., Carlton, M. B. L., Grosse, J., Schöneberg, T., Russ, A., et al. (2012) · Developmental Dynamics · doi:10.1002/dvdy.23841 · Cited by 74
Kiss, J., Szász, B. K., Fodor, L., Mike, Á., Lenkey, N., Kurkó, D., Nagy, J., & Vizi, E. S. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.005 · Cited by 72
Effect of mood stabilizers on DNA methylation in human neuroblastoma cells
Asai, T., Bundo, M., Sugawara, H., Sunaga, F., Ueda, J., Tanaka, G., Ishigooka, J., Kasai, K., Kato, T., & Iwamoto, K. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000710 · Cited by 68
Goswami, D. B., Jernigan, C. S., Chandran, A., Iyo, A. H., May, W. L., Austin, M. C., Stockmeier, C. A., & Karolewicz, B. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.010 · Cited by 59
Demars, M. P., & Morishita, H. (2014) · Molecular Brain · doi:10.1186/s13041-014-0075-9 · Cited by 51
Jiao, J., Opal, M. D., & Dulawa, S. C. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.136 · Cited by 47
Polymorphisms in the homeobox gene OTX2 may be a risk factor for bipolar disorder
Sabunciyan, S., Yolken, R. H., Ragan, C. M., Potash, J. B., Nimgaonkar, V. L., Dickerson, F., Llenos, I. C., & Weis, S. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30523 · Cited by 30
GIPR expression in gastric and duodenal neuroendocrine tumors
Sherman, S. K., Maxwell, J. E., Carr, J. C., Wang, D., O'Dorisio, M. S., O’Dorisio, T. M., & Howe, J. R. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.01.044 · Cited by 22
Epigenetic programing of depression during gestation
Dulawa, S. C. (2014) · BioEssays · doi:10.1002/bies.201300089 · Cited by 6
Cited by
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Liu, W., Ge, T., Leng, Y., Pan, Z., Fan, J., Yang, W., & Cui, R. (2017) · Neural Plasticity · doi:10.1155/2017/6871089 · Cited by 640
“The GRIN2A gene, which encodes the glutamatergic N-methyl-D-aspartate (NMDA) receptor subunit epsilon-1 in the prefrontal cortex, is probably disturbed in the regulation of synaptic plasticity in depression [69].”
BackgroundYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“In addition to the involvement of PFC synaptic dysregulation in depression, epigenetic changes have been described in the PFC of individuals with MDD. Twenty genes are found to be differentially methylated in PFC of MDD patients from a genome-wide methylation analysis, including hypermethylation of Grin2a [232].”
BackgroundYuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
“88 94 – 97 Another study comparing DNA methylation across the whole genome in live human brain tissue with that in peripheral (blood, saliva, and buccal) tissues concluded that the patterns unique to the target genomic region must be considered when selecting the best surrogate tissue to mimic…”
BackgroundBrain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 212
A review of DNA methylation in depression
Chen, D., Meng, L., Pei, F., Zheng, Y., & Leng, J. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.05.022 · Cited by 171
Metadata
- Authors
- Kaut, O., Schmitt, I., Hofmann, A., Hoffmann, P., Schlaepfer, T. E., Wüllner, U., & Hurlemann, R.
- Affiliations
- University of Bonn (DE)
- German Center for Neurodegenerative Diseases (DE)
- Life & Brain (Germany) (DE)
- University of Basel (CH)
- Corresponding author
- Kaut, Oliver
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2015-01-09
- Volume
- 265
- Issue
- 4
- Pages
- 331-341
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2022470748
- Cited by
- 68
- References
- 46
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 9 · 2021: 6 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 3 · 2015: 2
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, DNA methylation, NMDA receptor, GRIN2A, hippocampus, prefrontal cortex, epigenetics, recurrent depression, synaptic plasticity, glutamatergic signaling
- MeSH terms
- Aged, Aged, 80 and over, Major Depressive Disorder, Female, Gene Expression Regulation, Hippocampus, Humans, Male, Middle Aged, Netherlands, Postmortem Changes, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, DNA Methylation, Epigenesis, Genetic, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.